EUVIMED · CrossrefJournal
Asia-Pacific Journal of Clinical Oncology
ISSN 1743-7555 · Wiley
Latest articles
Contribution of Focal 1 8 F‐FDG Uptake on Positron Emission Tomography/Computed Tomography to Ultrasonography‐Based Malignancy Risk Assessment in Incidentally Detected Thyroid Nodules
Latent Profile Analysis of Reproductive Concerns in Thyroid Cancer Survivors: Implications for Stratified Fertility Preservation Interventions
Risk Factor Profiles May Differ Between Younger‐Onset and Late‐Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort
Transarterial Chemoembolization and Chemo‐Immunoembolization in Locally Advanced Rectal Cancer: An Updated Systematic Review
Real‐World Toxicity and Outcomes of KEYNOTE‐522‐Style Neoadjuvant Pembrolizumab for Triple‐Negative Breast Cancer in Australia
Convenor Welcome
COSA Committees
Highlighted Lectures and Awards
International Invited Speakers
Sponsor Acknowledgments
National Speakers
Program in Detail
Poster Listing
Exhibitor Listing
Oral Abstracts
Author Listing
Poster Abstracts
Issue Information
Real‐World Outcomes of Gemcitabine Plus Nab‐Paclitaxel Versus Modified FOLFIRINOX in Advanced Pancreatic Cancer
Does adjuvant chemotherapy in resected small bowel adenocarcinoma improve survival? A 10‐year retrospective analysis of treatment patterns and outcomes
Biomarker‐agnostic antibody‐drug conjugates in chemotherapy‐refractory metastatic colorectal cancer: a single‐centre retrospective pooled analysis of early‐phase clinical trials
Effect of certepetide (LSTA‐1) on immune system engagement against pancreatic ductal adenocarcinoma (PDAC): An iLSTA sub‐study
Initial results of the iLSTA study: Effect of certepetide (LSTA‐1) combined with immunotherapy and chemotherapy for locally advanced pancreatic ductal adenocarcinoma (PDAC)
Evaluation plasma 5‐fluorouracil (5‐FU) concentrations in patients with metastatic colorectal cancer
Patient acceptability and feasibility of finger‐prick blood sampling of 5‐FU in an Australian colorectal population (FFTV Study)
PROCEADE\xAE‐CRC‐03: A Phase 3 study of precemtabart tocentecan (Precem‐TcT), as monotherapy or plus bevacizumab, in patients with advanced metastatic colorectal cancer (mCRC)
Redo Cytoreductive Surgery and HIPEC for Recurrent Peritoneal Metastases: A Matched‐Cohort Study
Uptake of Extended Next‐Generation Sequencing and DPYD Testing in Metastatic Colorectal Cancer in Australia: A Multicentre, Real‐World Analysis
Analysing Survival Outcomes in Advanced Pancreatic Cancer: Benefit of Second and Later Line Therapy ‐ Real World Outcomes from the Australasian Purple Pancreatic Cancer Registry
Improving collaboration in Pancreatic Cancer Clinical Trials: The PURPLE Registry Trials Portal
EUVIMED